All In Biotech

Drug Trial Radar · NCT00118365

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Combination of DFMO and Sulindac to Decrease the Rate of Recurrence of Adenomatous Polyps in the Colon

Last checked: Nov 20, 2026Latest source record: Jan 22, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 375 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

375

Actual

Start

Jul 1998

Primary completion

Aug 2008

Study completion Aug 2008

Sponsor

Sponsor type
NIH
First posted
Jul 11, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized phase III trial is studying eflornithine and sulindac to see how well they work compared to a placebo in preventing colorectal cancer in patients with colon polyps. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of eflornithine and sulindac may prevent colorectal cancer. It is not yet known whether eflornithine and sulindac are more effective than a placebo in preventing colorectal cancer

Conditions

  • Precancerous Condition

Interventions

  • placeboOther

    Given orally

  • eflornithineDrug

    Given orally

  • sulindacDrug

    Given orally

  • laboratory biomarker analysisOther

    Correlative studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Detection of Any Adenoma at the End of the StudyTime frame: Up to 36 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California Medical Center At Irvine-Orange Campus

    Orange, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.